Teva Pharmaceutical News (NASDAQ:TEVA)

Latest Teva Pharmaceutical News Headlines
DateTimeSource
Headline
09/03/20082:00PMPRNUSTeva and Barr Receive FTC Request for Additional Information
JERUSALEM and MONTVALE, N.J., Sept. 3 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) and Barr Pharmaceuticals, Inc. (NYSE:BRL) announced today that, as expected, each party has received a request for additional information (commonly referred to as a "second request") from the U.S. Federal... More...>>
07/18/20087:00AMPRNUSTeva to Acquire Barr
Significantly Strengthens Teva's Market Leadership Position in the U.S. and in Key Global Markets JERUSALEM and MONTVALE, N.J., July 18 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) and Barr Pharmaceuticals, Inc. (NYSE:BRL) announced today that they have signed a definitive agreement under... More...>>
06/18/20089:00AMPRNUSBeaconEquity.com Issues TraderNotes on MCII, NOEC, MENT, HYHY, IVAN, RUNU, TEVA, CTXS
DALLAS, June 18 /PRNewswire/ -- BeaconEquity.com announces the availability of TraderNotes on stocks that are making news today. Investors can view all of the daily trading notes for free by visiting: http://www.beaconequity.com/m Today's TraderNotes include: Mariner's Choice (Pink Sheets: MCII), New Oriental Energy... More...>>
06/10/200811:20AMPRNUSSeven Summits Research Releases Comments on BIDU, TXN, FCX, BRCM, and TEVA
CHICAGO, June 10 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks. Seven Summits Strategic Investments NewsBites are available to all investors at: http://www.go7now.com/nb/0610Y (Note: You may have to copy this link into your browser then press the [ENTER] key.) Today's Seven Summits Strategic... More...>>
05/05/20089:31AMPRNUSSeven Summits Research Releases Comments on NYX, TEVA, DIS, ABX and EGLE
CHICAGO, May 5 /PRNewswire/ -- Seven Summits Strategic Investments releases its Stocks To Watch Guide. The Seven Summits Strategic Investments Stocks To Watch Guide (go to: http://www.iotogo.com/StocksToWatch) provides investors with essential information on stocks that may be poised for a significant move. By featuring... More...>>
04/21/20088:00AMPRNUS'Proud Hands' Book Released to Benefit the American Parkinson Disease Association
Teva Neuroscience Sponsors Book That Celebrates Daily Victories Over Parkinson's NEW YORK, April 21 /PRNewswire/ -- Most people view an illness as a handicap. A number of people with Parkinson's disease (PD), an age-related degenerative disorder of the brain which normally affects people over the age of 60, have each... More...>>
03/06/200812:56PMPRNUSPerrigo Company to Market Over-the-Counter Cetirizine Hydrochloride, Pseudoephedrine Hydrochloride Extended-Release Tablets
ALLEGAN, Mich., Mar. 6 /PRNewswire-FirstCall/ -- Perrigo Company (NASDAQ:PRGO)(TASE:PRGO) today announced that its partner, Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA), has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for over-the-counter... More...>>
01/15/20089:31AMPRNUSSeven Summits Research Releases Alerts on C, EMC, GRMN, TEVA, and DF
CHICAGO, Jan. 15 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks. Seven Summits Strategic Investments' PriceWatch Alerts are available at http://www.iotogo.com/s/011508A (Note: You may have to copy this link into your browser then press the [ENTER] key.) Today's PriceWatch Alerts cover... More...>>
10/22/20077:30AMPRNUSAdenoscan(R) Patent Lawsuits Settled
Astellas, King and Item finalize settlement agreement with Teva TOKYO, BRISTOL, Tenn., and JERUSALEM, Oct. 22 /PRNewswire/ -- Astellas Pharma Inc. ("Astellas"; headquarters: Tokyo; President and CEO: Masafumi Nogimori), King Pharmaceuticals, Inc. ("King"; NYSE: KG) and Teva Pharmaceutical Industries Ltd. ("Teva" Nasdaq:... More...>>
06/08/20078:03AMPRNUSInternational Movement Disorder Specialists Receive New Information About the Use of Once-Daily AZILECT(R) in the Treatment of P
Results presented at the Movement Disorder Society's 11th International Congress in Istanbul, Turkey KANSAS CITY, Mo., June 8 /PRNewswire-FirstCall/ -- New information on the use of AZILECT(R) (rasagiline tablets) for the treatment of Parkinson's disease (PD) was reported this week at The Movement Disorder Society's... More...>>
05/02/200711:47AMPRNUSSeven Summits Research Releases Comments on VZ, GRMN, TEVA, GPS, and USG
CHICAGO, May 2 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks. Seven Summits Strategic Investments NewsBites are available to all investors at: http://www.go7now.com/nb/0502Z (Note: You may have to copy this link into your browser then press the [ENTER] key.) Today's Seven Summits Strategic... More...>>
04/02/20071:09PMPRNUSDawson James Securities Reiterates Strong Buy Recommendation on Antares Pharma (Amex: AIS) with $4.00 Price Target
BOCA RATON, Fla., April 2 /PRNewswire/ -- Dawson James Securities, a full- service investment firm serving the healthcare and biotechnology industry, reiterated their Strong Buy recommendation on Antares Pharma (AMEX:AIS) and a 12-18 month price target of $4.00. Stephen M. Dunn, Director of Research, issued the report. The... More...>>
02/27/20078:15AMPRNUSVaccinex Announces Antibody Development and Commercialization Alliance in Multiple Sclerosis and Oncology
- Novel Antibody has Potential to Address Unmet Medical Need in Millions of Patients Worldwide - ROCHESTER, N.Y., Feb. 27 /PRNewswire/ -- Vaccinex, Inc. announced today that it has entered into a collaboration with Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) to develop and commercialize VX15, a novel human antibody... More...>>
01/18/200711:03AMPRNUSSeven Summits Research Releases Comments on EBAY, VZ, ERTS, NUE, and TEVA
CHICAGO, Jan. 18 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks. Seven Summits Strategic Investments NewsBites are available to all investors at http://www.go7now.com/nb.aspx?p=0118Z (Note: You may have to copy this link into your browser then press the [ENTER] key.) Today's Seven Summits... More...>>
12/22/20067:00AMPRNUSLargest Disease Modification Trial for Parkinson's Disease Completes Enrollment
Study to determine AZILECT(R) effect on slowing disease progression in approximately 1,200 recently diagnosed PD patients KANSAS CITY, Mo., Dec. 22 /PRNewswire-FirstCall/ -- The largest clinical study to investigate disease modification in early Parkinson's disease (PD) has completed enrollment. The ADAGIO (Attenuation... More...>>
11/06/20068:30AMPRNUSElbit Medical Group Announces Receipt of a Special Protocol Assessment From the FDA to Gamida Cell's Stemex(R) Registration Stud
More...>>
10/10/20068:30AMPRNUSNew Analyses Further Support Benefits of Once-Daily AZILECT(R) in the Treatment of Both Early and More Advanced Parkinson's Dise
Results Presented at the 131st American Neurological Association Meeting KANSAS CITY, Mo., Oct. 10 /PRNewswire-FirstCall/ -- New reports of AZILECT(R) (rasagiline tablets) as initial monotherapy, AZILECT(R) as first adjunctive therapy in moderate patients, and AZILECT(R) in combination with other adjunct agents in... More...>>
09/25/200611:20AMPRNUSSeven Summits Research Releases Comments on QCOM, AMR, LRCX, TEVA, and EK
CHICAGO, Sept. 25 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks. Seven Summits Strategic Investments NewsBites are available to all investors at http://www.go7now.com/nb.aspx?p=0925Z (Note: You may have to copy this link into your browser then press the [ENTER] key.) Today's Seven Summits... More...>>
09/14/200611:13AMPRNUSSeven Summits Research releases comments on OXY, XMSR, XLNX, TEVA, and PIR
CHICAGO, Sept. 14 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks. Seven Summits Strategic Investments NewsBites are available to all investors at http://www.go7now.com/nb.aspx?p=0914Z (Note: You may have to copy this link into your browser then press the [ENTER] key.) Today's Seven Summits... More...>>
08/01/200611:46AMPRNUSSeven Summits Research releases comments on GM, TEVA, IACI, HLT, and IP
CHICAGO, Aug. 1 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks. Seven Summits Strategic Investments NewsBites are available to all investors at http://www.go7now.com/Newsbites (Note: You may have to copy this link into your browser then press the [ENTER] key.) Today's Seven Summits Strategic... More...>>


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
34 site:2us nasdaq teva080906 02:29 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )